Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glyoxalase domain-containing protein 5 is a member of the glyoxalase gene family, characterized by its glyoxalase domain—structurally a βαβββ motif crucial for the coordination of divalent metal ions. The protein is encoded by the GLOD5 gene located on chromosome X (Xp11.23); several alternatively spliced variants are known, with predicted mitochondrial localization due to a targeting sequence. Expression is highest in the gastrointestinal tract. Unlike other glyoxalase family members (such as GLO1), the precise enzymatic activity, substrate specificity, and physiological role of GLOD5 remain unknown—as does its relevance to human disease or therapeutics. No knockout models, drug interactions, or mechanisms of action have been described, and its utility as a biomarker or safety concern in clinical use is unsupported. Further experimental studies are needed to elucidate its potential function and disease involvement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glyoxalase domain-containing protein 5 (GLOD5).